Facebook Linkedin RSS Twitter Youtube
Home 2024

Absci

Absci Eyes Busy 2025 as Lead AI-Designed Candidate Heads for Clinic
Artificial Intelligence

Absci Eyes Busy 2025 as Lead AI-Designed Candidate Heads for Clinic

With $86M Oversubscribed Public Offering, Absci Eyes 2025 IND for Lead Candidate
Artificial Intelligence

With $86M Oversubscribed Public Offering, Absci Eyes 2025 IND for Lead Candidate

Skin in the Game: Absci Partners with Almirall on Up-to-$650M Dermatology AI Collaboration
Drug Discovery

Skin in the Game: Absci Partners with Almirall on Up-to-$650M Dermatology AI Collaboration

Absci Eyes IND for Platform’s First de novo Antibody within Two Years
Drug Discovery

Absci Eyes IND for Platform’s First de novo Antibody within Two Years

Zero-Shot Moonshot: Absci Uses AI Platform to Create and Validate de novo Antibodies
Artificial Intelligence

Zero-Shot Moonshot: Absci Uses AI Platform to Create and Validate de novo Antibodies

Absci Forms Research Collaboration with Merck
Artificial Intelligence

Absci Forms Research Collaboration with Merck

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.